{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:19:17Z","timestamp":1769584757820,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRP"],"published-print":{"date-parts":[[2021,8,17]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Cardiac amyloidosis is a progressive infiltrative disease for which new treatments are\nnow available. As therapy should be started as early as possible to avoid complications such as restrictive\ncardiomyopathy, arrhythmias and heart failure, a prompt and reliable diagnosis by means\nof non-invasive tests would be highly warranted. Electrocardiography, echocardiography and cardiac\nmagnetic resonance imaging are all used in the evaluation of cardiac amyloidosis with varying\ndiagnostic and prognostic accuracy, but none of these modalities can effectively differentiate the\ncardiac amyloid subtypes. We aim to highlight the most relevant findings in the literature of molecular\nimaging in the assessment of patients with cardiac amyloidosis and to underline future clinical\nperspective. We performed multiple searches using Pub-Med databases in order to find important\noriginal articles on the role of molecular imaging in the assessment of patients affected by CA. Several\nsearch terms were used, such as \u201ccardiac amyloidosis\u201d; \u201cLight-chain amyloidosis\u201d; \u201cTransthyretin\namyloid cardiomyopathy\u201d; \u201cbone scintigraphy\u201d; \u201csingle photon emission tomography\u201d or\n\u201cSPECT\u201d; \u201cPositron emission tomography or PET\u201d, and \u201ccardiac imaging\u201d. All radiopharmaceuticals\ntracing cardiac amyloidosis were also included. Several studies about the role of SPECT with\nbone-seeking tracer (47 articles) and innervation tracer (9 articles) in the work-up of CA, as well as\nnew PET amyloid-binding (14 articles) and bone radiotracer (4 articles) have been reviewed and\ndiscussed. Molecular imaging represents a sensitive tool for early assessment of both amyloid burden\nand cardiac innervation, to differentiate between subtypes and to monitor disease burden, disease\nprogression, and potential response to therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874471013666200611105856","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T18:35:46Z","timestamp":1591900546000},"page":"228-241","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art"],"prefix":"10.2174","volume":"14","author":[{"given":"Cristina","family":"Popescu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene A.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182709","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182709\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T12:02:00Z","timestamp":1629806520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182709\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874471013666200611105856","relation":{},"ISSN":["1874-4710"],"issn-type":[{"value":"1874-4710","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}